Advertisement

Vascular Access

  • Simone CesaroEmail author
  • Federica Minniti

Abstract

The central venous catheter (CVC) is a key tool for patients undergoing a HSCT, and its introduction in the oncology setting has represented a clear improvement in the quality of patient health care. The use of a CVC requires correct maintenance to prevent malfunctioning due to partial or complete occlusion, dislodgement, kinking, rupture, thrombosis, or life-threatening complications such as catheter-related bloodstream infections (CRBSI).

References

  1. Blanco-Guzman MO. Implanted vascular access device options: a focus review on safety and outcomes. Transfusion. 2018;58:558–68.CrossRefGoogle Scholar
  2. Borretta L, MacDonald T, Digout C, et al. Peripherally inserted central catheters in pediatric oncology patients: a 15-year population-based review from Maritimes, Canada. J Pediatr Hematol Oncol. 2018;40:e55–60.PubMedGoogle Scholar
  3. Cesaro S, Cavaliere M, Pegoraro A, et al. A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients. Ann Hematol. 2016;95:817–25.CrossRefGoogle Scholar
  4. Cesaro S, Tridello G, Cavaliere M, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol. 2009;27:2059–65.CrossRefGoogle Scholar
  5. Cooling L. Performance and safety of femoral central venous catheters in pediatric autologous peripheral blood stem cell collection. J Clin Apher. 2017a;32:501–16.CrossRefGoogle Scholar
  6. Cooling L. Procedure-related complications and adverse events associated with pediatric autologous peripheral blood stem cell collection. J Clin Apher. 2017b;32:35–48.CrossRefGoogle Scholar
  7. Cornillon J, Martignoles JA, Tavernier-Tardy E, et al. Prospective evaluation of systematic use of peripherally inserted central catheters (PICC lines) for the home care after allogenic hematopoietic stem cells transplantation. Support Care Cancer. 2017;25:2843–7.CrossRefGoogle Scholar
  8. Crocoli A, Tornesello A, Pittiruti M,. et al. Central venous access devices in pediatric malignancies: a position paper of Italian Association of Pediatric Hematology and Oncology. J Vasc Access. 2015;16(2):130–6.CrossRefGoogle Scholar
  9. Frasca D, Dahyot-Fizelier C, Mimoz O. Prevention of central venous catheter-related infection in the intensive care unit. Crit Care. 2010;14:212.CrossRefGoogle Scholar
  10. Hashimoto Y, Fukuta T, Maruyama J, et al. Experience of peripherally inserted central venous catheter in patients with hematologic disease. Intern Med. 2017;56:389–93.CrossRefGoogle Scholar
  11. Hölig K, Blechschmidt M, Kramer M, et al. Peripheral blood stem cell collection in allogeneic donors: impact of venous access. Transfusion. 2012;52(12):2600–5.CrossRefGoogle Scholar
  12. Lee K, Ramaswamy RS. Intravascular access devices from an interventional radiology perspective: indications, implantation techniques, and optimizing patency. Transfusion. 2018;58(Suppl 1):549–57.CrossRefGoogle Scholar
  13. Lim HS, Kim SM, Kang DW. Implantable vascular access devices–past, present and future. Transfusion. 2018;58:545–8.CrossRefGoogle Scholar
  14. O’Leary MF. Venous access for hematopoietic progenitor cell collection: an international survey by the ASFA HPC donor subcommittee. J Clin Apher. 2016;31(6):529–34.CrossRefGoogle Scholar
  15. Padmanabhan A. Cellular collection by apheresis. Transfusion. 2018;58:598–604.CrossRefGoogle Scholar
  16. Ridyard CH, Plumpton CO, Gilbert RE, Hughes DA. Cost-effectiveness of pediatric central venous catheters in the UK: a secondary publication from the CATCH clinical trial. Front Pharmacol. 2017;8:644.CrossRefGoogle Scholar
  17. Ullman AJ, Cooke ML, Mitchell M, et al., Dressings and securement devices for central venous catheters (CVC). Cochrane Database Syst Rev. 2015;(9):CD010367.Google Scholar
  18. Vacca M, Perseghin P, Accorsi P, et al. Central venous catheter insertion in peripheral blood hematopoietic stem cell sibling donors: the SIdEM (Italian Society of Hemapheresis and Cell Manipulation) point of view. Transfus Apher Sci. 2014;50:200–6.CrossRefGoogle Scholar
  19. Wildgruber M, Lueg C, Borgmeyer S, et al. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm. Eur J Cancer. 2016;59:113–24.CrossRefGoogle Scholar

Copyright information

© EBMT and the Author(s) 2019

Open Access  This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The images or other third party material in this chapter are included in the chapter’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Authors and Affiliations

  1. 1.Pediatric Hematology OncologyAzienda Ospedaliera Universitaria IntegrataVeronaItaly
  2. 2.Mother and Child DepartmentOspedale della Donna e del Bambino, University of VeronaVeronaItaly

Personalised recommendations